Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial).
Authors: Kaye S, Loveday C, Gibb DM., Newberry A.
Published in: IVth International Congress Glasgow, 8-12 November 1998. Abstract P305